SHARPIN is modulator of the NF-kB pathway, and SHARPIN up-regulation promotes cell proliferation, migration, invasion and chemoresistance in prostate cancer by affecting the downstream targets survivin and livin [45]. This evidence concerns the gene NFKB1 and prostate cancer.